Immix Biopharma Ownership | Who Owns Immix Biopharma?
Immix Biopharma Ownership Summary
Immix Biopharma is owned by 103.30% institutional investors, 14.62% insiders. Janus henderson group is the largest institutional shareholder, holding 12.54% of IMMX shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 5.44% of its assets in Immix Biopharma shares.
IMMX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immix Biopharma | 103.30% | 14.62% | -17.92% |
| Sector | Healthcare Stocks | 128.69% | 12.02% | -40.72% |
| Industry | Biotech Stocks | 180.58% | 11.62% | -92.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 4.80M | 12.54% | $43.70M |
| Saturn v capital management | 3.69M | 9.65% | $33.65M |
| Eventide asset management | 5.19M | 8.13% | $53.97M |
| Blackrock funding, inc. /de | 4.54M | 7.12% | $47.24M |
| State street | 3.30M | 5.18% | $34.38M |
| Vanguard capital management | 3.00M | 4.71% | $31.24M |
| Millennium management | 1.75M | 4.57% | $15.94M |
| Vanguard group | 1.10M | 3.43% | $5.73M |
| Logos global management lp | 1.23M | 3.20% | $11.16M |
| Marshall wace, llp | 1.85M | 2.91% | $19.28M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Monashee investment management | 450.00K | 14.02% | $4.68M |
| Saturn v capital management | 3.69M | 6.09% | $33.65M |
| Velan capital investment management lp | 740.00K | 4.22% | $6.74M |
| Kvp capital advisors, lp | 230.42K | 1.93% | $2.40M |
| Imprint wealth | 31.25K | 1.30% | $284.67K |
| Blue owl capital lp | 602.05K | 1.14% | $6.26M |
| Bleichroeder lp | 1.00M | 1.02% | $10.40M |
| Eventide asset management | 5.19M | 0.76% | $53.97M |
| Great point partners | 350.00K | 0.73% | $3.19M |
| Logos global management lp | 1.23M | 0.56% | $11.16M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 4.54M | 0.00% | 1.55M |
| Eventide asset management | 5.19M | 0.76% | 1.30M |
| Janus henderson group | 4.80M | 0.02% | 880.43K |
| Abrdn | 818.67K | 0.01% | 818.67K |
| Franklin resources | 1.79M | 0.00% | 818.18K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 186.50K | 0.00% | -1.76M |
| Adage capital partners gp | - | - | -1.50M |
| Aigh capital management | - | - | -1.12M |
| Cable car capital | - | - | -779.36K |
| Ameriprise financial | - | - | -452.15K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Abrdn | 818.67K | 0.01% | 818.67K | $8.52M |
| Monashee investment management | 450.00K | 14.02% | 450.00K | $4.68M |
| Price t rowe associates inc /md/ | 415.00K | 0.00% | 415.00K | $3.78M |
| Great point partners | 350.00K | 0.73% | 350.00K | $3.19M |
| Picton mahoney asset management | 333.25K | 0.02% | 333.25K | $3.47M |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -11.00 |
| Fortitude family office | -53.00 |
| Raymond james financial | -525.00 |
| Group one trading | -879.00 |
| Tortoise investment management | -1.30K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 144 | 26.32% | 65,875,401 | 16.91% | 103 | 1.32% | 105 | 26.51% | 22 | 83.33% |
| Jun 30, 2026 | 114 | 44.30% | 56,354,585 | 108.13% | 88 | 3.70% | 82 | 60.78% | 13 | -7.14% |
| Mar 31, 2026 | 25 | -63.77% | 3,096,764 | -87.30% | 8 | 0.14% | 18 | -68.42% | 3 | -57.14% |
| Dec 31, 2025 | 31 | -3.13% | 9,543,371 | 243.79% | 29 | 34.87% | 27 | 28.57% | 4 | 33.33% |
| Sep 30, 2025 | 26 | 18.18% | 1,748,673 | -18.18% | 5 | 11.48% | 16 | 77.78% | 3 | -25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 3.89M | 5.44% | 1.34M |
| Janus Henderson Hrzn Biotec E2 USD | 1.95M | 2.74% | 495.89K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.24M | 2.70% | 456.50K |
| State Street® SPDR® S&P® Biotech ETF | 2.21M | 2.66% | 57.74K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.78M | 2.50% | 494.90K |
| Vanguard Total Stock Mkt Idx Inv | 1.78M | 2.50% | 494.90K |
| iShares Russell 2000 ETF | 1.50M | 1.81% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.14M | 1.38% | 530.12K |
| Columbia Small Cap Growth Inst | 986.32K | 1.19% | 236.70K |
| Janus Henderson Global Life Sciences D | 842.40K | 1.02% | 842.40K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $4.98K |
| Dec 10, 2025 | Morris Gabriel S | CFO | Buy | $5.07K |
| Sep 17, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $5.05K |
| Sep 16, 2025 | Morris Gabriel S | CFO | Buy | $5.12K |
| Jun 18, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $5.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 2 | - |
| 2025 Q3 | 2 | - |
| 2025 Q2 | 2 | - |
| 2024 Q4 | 2 | - |
| 2024 Q3 | 5 | - |
IMMX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools